Companies Hub

Platform Leader

Emulate

FDA ISTAND-qualified Liver-Chip. 87% sensitivity for DILI prediction. Wyss Institute spinout.

View Profile →

Multi-Organ

CN Bio

PhysioMimix multi-organ MPS. Liver, gut, and multi-organ platforms for ADME-Tox.

View Profile →

Body-on-Chip

Hesperos

Human-on-a-Chip platform. Multi-organ pumpless systems for systemic drug response.

View Profile →

HUMIMIC

TissUse

HUMIMIC multi-organ chips. German engineering for systemic pharmacology.

View Profile →

OrganoPlate

Mimetas

OrganoPlate 3-lane microfluidic platform. High-throughput organ-on-chip.

View Profile →

Neural

AxoSim

Nerve-on-chip technology. Peripheral nerve and CNS models.

View Profile →

Biobank

HUB Organoids

Netherlands biobank. Acquired by Merck Dec 2024. Hans Clevers founded.

View Profile →

Tumor Models

Crown Bioscience

HuTumorX organoid platform. Patient-derived tumor models.

View Profile →

3D InSight

InSphero

3D InSight liver and islet microtissues. Scaffold-free spheroids.

View Profile →

AI Platform

Recursion

$1B+ AI drug discovery. Acquired Cyclica, Valence. Nvidia partnership.

View Profile →

Generative AI

Insilico Medicine

Chemistry42, Biology42. AI-designed drugs in clinical trials.

View Profile →

Bio-AI

Quris AI

Patient-on-chip + AI integration. Predictive toxicology platform.

View Profile →